The FDA approved a label update Friday for Pfizer's Depo-Provera birth control shot warning of meningioma—a brain tumor in the lining—after studies dating back to 1983 linked high-dose progestin to ...

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with the birth control shot.

Evidence indicates that Depo-Provera can cause specific mutations in women's DNA. Given the availability of alternatives without this known risk, the continued use of the shot difficult to justify.” — ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental briefs ...

Meningiomas are the most common primary brain tumor. They arise from the membranes surrounding the brain and spinal cord and are usually benign. They have a clear predominance in women, with ...

Provera’s label to include a warning about meningioma, a type of brain tumour. The change follows studies and a lawsuit ...